undefined undefined
NaN.000
NaN.00%
Gainers: Processa Pharmaceuticals (PCSA) +45%. NewGenIvf Group (NIVF) +18%. Cidara Therapeutics (CDTX) +13%. Predictive Oncology (POAI) +10%. Zura Bio (ZURA) +6%. Losers: Cyclacel Pharmaceuticals (CYC...
04-25 22:00
Shares of Bristol-Myers Squibb dipped in the premarket Thursday even as the company’s Q1 2024 results exceeded expectations amid headwinds to key components in its growth portfolio dominated by its ca...
04-25 19:56
A new class of cancer treatments called CAR-T cell therapies will require updates to their safety information to indicate a severe risk of secondary malignancies, according to the U.S. Food and Drug A...
04-19 18:13
花旗:维持2seventy bio(TSVT.US)评级,由买入调整至买入评级, 目标价由9.00美元调整至12.00美元。
04-09 06:22
Johnson & Johnson (NYSE:JNJ) has received FDA approval to expand the current labeling for its CAR-T cell therapy, Carvykti, developed in partnership with Legend Biotech (NASDAQ:LEGN), to include adult...
04-06 20:38
Wall Street made solid gains on Friday, after the latest nonfarm payrolls report signaled cooling inflation and a U.S. economy that was powering ahead of others. The advance came despite the data also...
04-06 01:13
An update from 2seventy bio (TSVT) is now available. 2seventy bio, Inc. and Bri...
04-05 21:32
Gainers: Signature Bank (OTC:SBNY) +10%. MacroGenics (MGNX) +9%. Simulations Plus (SLP) +7%. Annexon (ANNX) +6%. 2seventy (TSVT) +5%. Losers: Cadiz (CDZIP) -11%. Starbucks Corporation (SBUX) -7%. LAM...
04-04 05:24
2seventy bio (TSVT) just unveiled an update. 2seventy bio, Inc. has completed t...
04-01 20:02
施贵宝表示,其CAR T细胞疗法Abecma治疗复发或难治性多发性骨髓瘤已获得欧盟监管部门的批准。
03-21 10:38